{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [
    [
      "COVID-19",
      "Calcium channel blocker",
      "Hypertension",
      "Mortality",
      "Severity"
    ]
  ],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "34298269",
  "DateCompleted": {
    "Year": "2021",
    "Month": "10",
    "Day": "04"
  },
  "DateRevised": {
    "Year": "2022",
    "Month": "12",
    "Day": "07"
  },
  "Article": {
    "ArticleDate": [
      {
        "Year": "2021",
        "Month": "07",
        "Day": "16"
      }
    ],
    "Language": [
      "eng"
    ],
    "ELocationID": [
      "10.1016/j.dsx.2021.102210",
      "S1871-4021(21)00230-7"
    ],
    "Journal": {
      "ISSN": "1878-0334",
      "JournalIssue": {
        "Volume": "15",
        "Issue": "5",
        "PubDate": {
          "Year": "2021",
          "Season": "Sep-Oct"
        }
      },
      "Title": "Diabetes & metabolic syndrome",
      "ISOAbbreviation": "Diabetes Metab Syndr"
    },
    "ArticleTitle": "Association of calcium channel blocker use with clinical outcome of COVID-19: A meta-analysis.",
    "Pagination": {
      "StartPage": "102210",
      "MedlinePgn": "102210"
    },
    "Abstract": {
      "AbstractText": [
        "This meta-analysis aims to analyze the association of calcium channel blocker (CCB) use with COVID-19 clinical outcomes.",
        "PubMed, ProQuest, Science Direct, Scopus, and medRxiv databases were searched systematically in a limited period. The primary outcome was mortality.",
        "A total of 119,298 patients from 31 eligible studies were included. Pooled analysis of the random-effect model revealed CCB was not associated with reduced mortality (OR\u00a0=\u00a01.21 [95%CI: 0.98-1.49], p\u00a0=\u00a00.08). Interestingly, subgroup analysis in hypertensive patients revealed significantly reduced mortality (OR\u00a0=\u00a00.69 [95%CI: 0.52-0.91], p\u00a0=\u00a00.009).",
        "CCB usage was not associated with the outcome of COVID-19. However, CCB was associated with a decreased mortality rate in hypertensive COVID-19 patients."
      ],
      "CopyrightInformation": "Copyright \u00a9 2021 Diabetes India. Published by Elsevier Ltd. All rights reserved."
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Faculty of Medicine, Universitas Airlangga, Surabaya, Indonesia; Department of Cardiology and Vascular Medicine, Dr. Soetomo General Hospital, Surabaya, Indonesia; Universitas Airlangga Hospital, Surabaya, Indonesia. Electronic address: yusuf_505@fk.unair.ac.id."
          }
        ],
        "LastName": "Alsagaff",
        "ForeName": "Mochamad Yusuf",
        "Initials": "MY"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Faculty of Medicine, Universitas Airlangga, Surabaya, Indonesia; Department of Cardiology and Vascular Medicine, Dr. Soetomo General Hospital, Surabaya, Indonesia."
          }
        ],
        "LastName": "Mulia",
        "ForeName": "Eka Prasetya Budi",
        "Initials": "EPB"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Faculty of Medicine, Universitas Airlangga, Surabaya, Indonesia; Department of Cardiology and Vascular Medicine, Dr. Soetomo General Hospital, Surabaya, Indonesia."
          }
        ],
        "LastName": "Maghfirah",
        "ForeName": "Irma",
        "Initials": "I"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Faculty of Medicine, Universitas Airlangga, Surabaya, Indonesia."
          }
        ],
        "LastName": "Luke",
        "ForeName": "Kevin",
        "Initials": "K"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Faculty of Medicine, Universitas Airlangga, Surabaya, Indonesia."
          }
        ],
        "LastName": "Nugraha",
        "ForeName": "David",
        "Initials": "D"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Faculty of Medicine, Universitas Airlangga, Surabaya, Indonesia; Department of Cardiology and Vascular Medicine, Dr. Soetomo General Hospital, Surabaya, Indonesia."
          }
        ],
        "LastName": "Rachmi",
        "ForeName": "Dita Aulia",
        "Initials": "DA"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Faculty of Medicine, Universitas Airlangga, Surabaya, Indonesia; Department of Cardiology and Vascular Medicine, Dr. Soetomo General Hospital, Surabaya, Indonesia."
          }
        ],
        "LastName": "Septianda",
        "ForeName": "Imanita",
        "Initials": "I"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Faculty of Medicine, Universitas Airlangga, Surabaya, Indonesia; Department of Cardiology and Vascular Medicine, Dr. Soetomo General Hospital, Surabaya, Indonesia."
          }
        ],
        "LastName": "A'yun",
        "ForeName": "Maya Qurota",
        "Initials": "MQ"
      }
    ],
    "PublicationTypeList": [
      "Journal Article",
      "Meta-Analysis",
      "Systematic Review"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "Netherlands",
    "MedlineTA": "Diabetes Metab Syndr",
    "NlmUniqueID": "101462250",
    "ISSNLinking": "1871-4021"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Angiotensin Receptor Antagonists"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Angiotensin-Converting Enzyme Inhibitors"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Calcium Channel Blockers"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [],
      "DescriptorName": "Adult"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Aged"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Aged, 80 and over"
    },
    {
      "QualifierName": [
        "therapeutic use"
      ],
      "DescriptorName": "Angiotensin Receptor Antagonists"
    },
    {
      "QualifierName": [
        "therapeutic use"
      ],
      "DescriptorName": "Angiotensin-Converting Enzyme Inhibitors"
    },
    {
      "QualifierName": [
        "diagnosis",
        "mortality"
      ],
      "DescriptorName": "COVID-19"
    },
    {
      "QualifierName": [
        "therapeutic use"
      ],
      "DescriptorName": "Calcium Channel Blockers"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Female"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [
        "diagnosis",
        "drug therapy",
        "mortality"
      ],
      "DescriptorName": "Hypertension"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Male"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Middle Aged"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Mortality"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Prognosis"
    },
    {
      "QualifierName": [
        "drug effects",
        "physiology"
      ],
      "DescriptorName": "SARS-CoV-2"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Severity of Illness Index"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Treatment Outcome"
    },
    {
      "QualifierName": [
        "drug effects"
      ],
      "DescriptorName": "Virus Internalization"
    },
    {
      "QualifierName": [],
      "DescriptorName": "COVID-19 Drug Treatment"
    }
  ],
  "CoiStatement": "Declaration of competing interest The authors declare no competing interest in this article."
}